D.E. Shaw & Co’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $168K | Sell |
47,938
-69,508
| -59% | -$285K | ﹤0.01% | 4230 |
|
|
2025
Q4 | $396K | Sell |
117,446
-254,824
| -68% | -$662K | ﹤0.01% | 4034 |
|
|
2025
Q3 | $488K | Sell |
372,270
-1,297,369
| -78% | -$1.34M | ﹤0.01% | 3873 |
|
|
2025
Q2 | $1.2M | Buy |
1,669,639
+1,559,915
| +1,422% | +$1.22M | ﹤0.01% | 3112 |
|
|
2025
Q1 | $161K | Buy |
109,724
+41,971
| +62% | +$100K | ﹤0.01% | 3959 |
|
|
2024
Q4 | $300K | Sell |
67,753
-176,928
| -72% | -$718K | ﹤0.01% | 3887 |
|
|
2024
Q3 | $1.01M | Sell |
244,681
-140,268
| -36% | -$754K | ﹤0.01% | 3266 |
|
|
2024
Q2 | $2.51M | Buy |
384,949
+96,296
| +33% | +$681K | ﹤0.01% | 2457 |
|
|
2024
Q1 | $2.51M | Buy |
288,653
+59,623
| +26% | +$723K | ﹤0.01% | 2451 |
|
|
2023
Q4 | $2.62M | Sell |
229,030
-207,233
| -48% | -$2.05M | ﹤0.01% | 2461 |
|
|
2023
Q3 | $4.2M | Sell |
436,263
-482,735
| -53% | -$4.73M | ﹤0.01% | 1955 |
|
|
2023
Q2 | $9.78M | Buy |
918,998
+118,275
| +15% | +$1.27M | 0.01% | 1358 |
|
|
2023
Q1 | $8.42M | Buy |
800,723
+173,337
| +28% | +$1.94M | 0.01% | 1501 |
|
|
2022
Q4 | $7.77M | Buy |
627,386
+69,952
| +13% | +$793K | 0.01% | 1672 |
|
|
2022
Q3 | $5.78M | Sell |
557,434
-193,995
| -26% | -$2.2M | 0.01% | 1928 |
|
|
2022
Q2 | $8.66M | Sell |
751,429
-434,953
| -37% | -$5.12M | 0.01% | 1523 |
|
|
2022
Q1 | $14.9M | Buy |
1,186,382
+302,288
| +34% | +$3.47M | 0.01% | 1253 |
|
|
2021
Q4 | $10.3M | Sell |
884,094
-441,333
| -33% | -$5.41M | 0.01% | 1641 |
|
|
2021
Q3 | $17.3M | Buy |
1,325,427
+341,189
| +35% | +$4.41M | 0.02% | 1117 |
|
|
2021
Q2 | $12.7M | Sell |
984,238
-536,802
| -35% | -$6.14M | 0.01% | 1309 |
|
|
2021
Q1 | $17M | Sell |
1,521,040
-618,187
| -29% | -$6.53M | 0.02% | 1022 |
|
|
2020
Q4 | $24.4M | Buy |
2,139,227
+290,922
| +16% | +$3.18M | 0.02% | 851 |
|
|
2020
Q3 | $16.6M | Buy |
1,848,305
+134,118
| +8% | +$1.33M | 0.02% | 941 |
|
|
2020
Q2 | $17.7M | Buy |
1,714,187
+45,398
| +3% | +$465K | 0.02% | 849 |
|
|
2020
Q1 | $16.8M | Buy |
1,668,789
+203,163
| +14% | +$2.39M | 0.03% | 720 |
|
|
2019
Q4 | $19.5M | Buy |
1,465,626
+797,330
| +119% | +$8.79M | 0.02% | 833 |
|
|
2019
Q3 | $5.74M | Buy |
668,296
+30,942
| +5% | +$301K | 0.01% | 1547 |
|
|
2019
Q2 | $6.97M | Sell |
637,354
-541,759
| -46% | -$6.07M | 0.01% | 1354 |
|
|
2019
Q1 | $13.4M | Buy |
1,179,113
+320,099
| +37% | +$3.57M | 0.02% | 932 |
|
|
2018
Q4 | $7.45M | Buy |
859,014
+572,478
| +200% | +$6.57M | 0.01% | 1276 |
|
|
2018
Q3 | $4.43M | Buy |
286,536
+149,454
| +109% | +$2.36M | 0.01% | 1648 |
|
|
2018
Q2 | $2.19M | Sell |
137,082
-68,728
| -33% | -$1.02M | ﹤0.01% | 2160 |
|
|
2018
Q1 | $2.66M | Sell |
205,810
-173,406
| -46% | -$2.16M | ﹤0.01% | 1843 |
|
|
2017
Q4 | $4.76M | Buy |
379,216
+30,739
| +9% | +$401K | 0.01% | 1514 |
|
|
2017
Q3 | $4.6M | Buy |
348,477
+44,025
| +14% | +$606K | 0.01% | 1436 |
|
|
2017
Q2 | $4.81M | Sell |
304,452
-321,913
| -51% | -$4.68M | 0.01% | 1366 |
|
|
2017
Q1 | $8.95M | Sell |
626,365
-125,848
| -17% | -$1.72M | 0.02% | 944 |
|
|
2016
Q4 | $9.63M | Buy |
752,213
+132,500
| +21% | +$1.67M | 0.02% | 960 |
|
|
2016
Q3 | $8.24M | Buy |
619,713
+266,940
| +76% | +$3.12M | 0.01% | 1001 |
|
|
2016
Q2 | $3.86M | Sell |
352,773
-32,891
| -9% | -$321K | 0.01% | 1444 |
|
|
2016
Q1 | $3.53M | Buy |
385,664
+39,009
| +11% | +$322K | 0.01% | 1509 |
|
|
2015
Q4 | $3.37M | Buy |
346,655
+128,884
| +59% | +$1.25M | 0.01% | 1727 |
|
|
2015
Q3 | $1.9M | Sell |
217,771
-485,624
| -69% | -$4.53M | ﹤0.01% | 2136 |
|
|
2015
Q2 | $7.11M | Sell |
703,395
-341,257
| -33% | -$3.97M | 0.01% | 1233 |
|
|
2015
Q1 | $14M | Buy |
1,044,652
+184,696
| +21% | +$2.42M | 0.02% | 782 |
|
|
2014
Q4 | $11M | Buy |
859,956
+220,932
| +35% | +$2.53M | 0.01% | 1047 |
|
|
2014
Q3 | $6.93M | Buy |
639,024
+491,389
| +333% | +$5.63M | 0.01% | 1344 |
|
|
2014
Q2 | $1.9M | Buy |
147,635
+90,377
| +158% | +$983K | ﹤0.01% | 2351 |
|
|
2014
Q1 | $591K | Sell |
57,258
-3,657
| -6% | -$41.1K | ﹤0.01% | 3456 |
|
|
2013
Q4 | $592K | Sell |
60,915
-26,536
| -30% | -$238K | ﹤0.01% | 3605 |
|
|
2013
Q3 | $868K | Sell |
87,451
-84,742
| -49% | -$831K | ﹤0.01% | 3168 |
|
|
2013
Q2 | $1.44M | Buy |
+172,193
| New | +$2.09M | ﹤0.01% | 2420 |
|
Other funds holding IRWD
AC
SCM
VPM
VCM
D.E. Shaw & Co's IRWD Position: Q1 2026 in Review
D.E. Shaw & Co reduced its Ironwood Pharmaceuticals (IRWD) stake by 59% in Q1 2026, selling an estimated $285K and leaving 47,938 shares worth $168K. The position accounts for ﹤0.01% of the portfolio, ranked #4230.
D.E. Shaw & Co first reported a position in IRWD in Q2 2013 and has held it in 52 quarters since. The position peaked at $24.4M in Q4 2020. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.
- D.E. Shaw & Co held 47,938 shares of Ironwood Pharmaceuticals worth $168K as of Q1 2026.
- D.E. Shaw & Co sold 69,508 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $285K.
- Ironwood Pharmaceuticals made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #4230 holding.
- D.E. Shaw & Co first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- D.E. Shaw & Co's Ironwood Pharmaceuticals position peaked at $24.4M in Q4 2020.
- 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.